Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis

被引:205
作者
Vokurka, M. [1 ]
Krijt, J. [1 ]
Sulc, K. [1 ]
Necas, E. [1 ]
机构
[1] Charles Univ Prague, Fac Med 1, Inst Pathophysiol, U Nemocnice 5, Prague, Czech Republic
关键词
iron; hepcidin; liver; erythropoiesis; gene expression;
D O I
10.33549/physiolres.930841
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Hepcidin, a key regulator of iron metabolism, decreases intestinal absorption of iron and its release from macrophages. Iron, anemia, hypoxia, and inflammation were reported to influence hepcidin expression. To investigate regulation of the expression of hepcidin and other iron-related genes, we manipulated erythropoietic activity in mice. Erythropoiesis was inhibited by irradiation or posttransfusion polycythemia and stimulated by phenylhydrazine administration and erythropoietin. Gene expression of hepcidin and other iron-related genes (hemojuvelin, DMT1, ferroportin, transferrin receptors, ferritin) in the liver was measured by the real-time polymerase chain reaction. Hepcidin expression increased despite severe anemia when hematopoiesis was inhibited by irradiation. Suppression of erythropoiesis by posttransfusion polycythemia or irradiation also increased hepcidin mRNA levels. Compensated hemolysis induced by repeated phenylhydrazine administration did not change hepcidin expression. The decrease caused by exogenous erythropoeitin was blocked by postirradiation bone marrow suppression. The hemolysis and anemia decrease hepcidin expression only when erythropoiesis is functional; on the other hand, if erythropoiesis is blocked, even severe anemia does not lead to a decrease of hepcidin expression, which is indeed increased. We propose that hepcidin is exclusively sensitive to iron utilization for erythropoiesis and hepatocyte iron balance, and these changes are not sensed by other genes involved in the control of iron metabolism in the liver.
引用
收藏
页码:667 / 674
页数:8
相关论文
共 30 条
  • [1] Decreased hepcidin mRNA expression in thalassemic mice
    Adamsky, K
    Weizer, O
    Amariglio, N
    Breda, L
    Harmelin, A
    Rivella, S
    Rachmilewitz, E
    Rechavi, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (01) : 123 - 124
  • [2] Decreased liver hepcidin expression in the Hfe knockout mouse
    Ahmad, KA
    Ahmann, JR
    Migas, MC
    Waheed, A
    Britton, RS
    Bacon, BR
    Sly, WS
    Fleming, RE
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2002, 29 (03) : 361 - 366
  • [3] Chemistry and biology of eukaryotic iron metabolism
    Aisen, P
    Enns, C
    Wessling-Resnick, M
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (10) : 940 - 959
  • [4] Pumping iron: The proteins
    Beutler, E
    [J]. SCIENCE, 2004, 306 (5704) : 2051 - 2053
  • [5] STUDIES ON CONGENITAL HEMOLYTIC SYNDROMES .4. GASTROINTESTINAL ABSORPTION OF IRON
    ERLANDSON, ME
    WEHMAN, J
    WALDEN, B
    SMITH, CH
    HILGARTNER, MW
    STERN, G
    [J]. BLOOD, 1962, 19 (03) : 359 - &
  • [6] Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats
    Frazer, DM
    Wilkins, SJ
    Becker, EM
    Vulpe, CD
    McKie, AT
    Trinder, D
    Anderson, GJ
    [J]. GASTROENTEROLOGY, 2002, 123 (03) : 835 - 844
  • [7] Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis
    Frazer, DM
    Inglis, HR
    Wilkins, SJ
    Millard, KN
    Steele, TM
    McLaren, GD
    McKie, AT
    Vulpe, CD
    Anderson, GJ
    [J]. GUT, 2004, 53 (10) : 1509 - 1515
  • [8] Hepcidin - a regulator of intestinal iron absorption and iron recycling by macrophages
    Ganz, T
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) : 171 - 182
  • [9] Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis
    Kawabata, H
    Fleming, RE
    Gui, D
    Moon, SY
    Saitoh, T
    O'Kelly, J
    Umehara, Y
    Wano, Y
    Said, JW
    Koeffler, HP
    [J]. BLOOD, 2005, 105 (01) : 376 - 381
  • [10] LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
    Krause, A
    Neitz, S
    Mägert, HJ
    Schulz, A
    Forssmann, WG
    Schulz-Knappe, P
    Adermann, K
    [J]. FEBS LETTERS, 2000, 480 (2-3) : 147 - 150